Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rein Therapeutics (RNTX) Preferred Dividend Payments (2016 - 2017)

Rein Therapeutics (RNTX) has disclosed Preferred Dividend Payments for 2 consecutive years, with $21000.0 as the latest value for Q2 2017.

  • Quarterly Preferred Dividend Payments rose 10.53% to $21000.0 in Q2 2017 from the year-ago period, while the trailing twelve-month figure was $41000.0 through Dec 2017, down 45.33% year-over-year, with the annual reading at $41000.0 for FY2017, 45.33% down from the prior year.
  • Preferred Dividend Payments for Q2 2017 was $21000.0 at Rein Therapeutics, up from $20000.0 in the prior quarter.
  • The five-year high for Preferred Dividend Payments was $21000.0 in Q2 2017, with the low at $18000.0 in Q1 2016.